Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Pfizer Consumer Healthcare

02 5Pfizer Inc

03 1Wyeth Pharmaceuticals Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab ozogamicin

Brand Name : Mylotarg

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab ozogamicin

Brand Name : Mylotarg

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab ozogamicin

Brand Name : Mylotarg

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab ozogamicin

Brand Name : Mylotarg

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab Ozogamicin

Brand Name : Mylotarg

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 5mg

Packaging :

Approval Date : 19/04/2018

Application Number : 20161206000103

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab Ozogamicin

Brand Name : Mylotarg

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 5mg

Packaging :

Approval Date : 05/12/2019

Application Number : 66879

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

GEMTUZUMAB OZOGAMICIN

Brand Name : MYLOTARG

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 4.5MG/VIAL

Packaging :

Approval Date :

Application Number : 2494388

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab ozogamicin

Brand Name : Mylotarg

Dosage Form : INJ

Dosage Strength : 5mg

Packaging : 5X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Gemtuzumab Ozogamicin

Brand Name : Mylotarg

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 5MG

Packaging :

Approval Date : 2018-05-25

Application Number : 1181277001

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

GEMTUZUMAB OZOGAMICIN

Brand Name : MYLOTARG

Dosage Form : VIAL;SINGLE-DOSE

Dosage Strength : 4.5MG

Packaging :

Approval Date :

Application Number : 761060

Regulatory Info :

Registration Country : USA

blank